In EU, the Biocidal Products Regulation (BPR) refers to Regulation (EU) 528/2012) concerning the placing on the market and use of biocidal products.
It repeals the Biocidal Products Directive (Directive 98/8/EC) and comes into force on 1 Sept 2013.
The regulation not only impacts manufacturers and importers of biocidal products, but also affects article producers who use biocidal products to treat their products.If a manufacturer or importer does not register the substances he manufactures or imports, then there will be no data available and so he will not be able to manufacture or import them legally.
The key requirement of BPR regulation is that all biocidal products require an authorisation by European Chemicals Agency (ECHA) before they can be placed on the EU market, and the active substances contained in that biocidal product must be previously approved.
The Biocidal Products Regulation (BPR) also sets rules for the use of articles treated with, or intentionally incorporating, one or more biocidal products. Articles can only be treated with biocidal products containing active substances approved in the EU. This also applies to articles manufactured outside of EU. Some treated articles require additional labelling.
- Overview of EU regulation of biocidal products and critical legislative concepts
- Authorisationof biocidal products and approval of their active substances
- Transitional regime
- Treated articles
- IT tools
Who should attend
Anyone with a responsibility for and/or interest in placing biocidal products and treated articles on EU market including:
- Producers and Importers into EU
- Non-EU companiesPresenter
PaedDr. Alena Pilvanova, BPR expert